Core Viewpoint - Haimer Technology has announced a restricted stock incentive plan for 2025, aiming to strengthen the alignment of interests between its core team and the company's long-term development [1][2]. Group 1: Incentive Plan Details - The company plans to grant restricted stocks to no more than 107 individuals, totaling up to 41.065 million shares, which represents 8.05% of the company's total share capital at the time of the announcement [1]. - The grant price is set at 4.82 yuan per share, indicating a strategic move to enhance organizational cohesion and execution capabilities [1]. Group 2: Organizational Adjustments - Concurrently with the incentive plan, the company has optimized its organizational structure, establishing a new M&A Investment Department to enhance its professional capabilities in industrial investment and due diligence [2]. - Key personnel adjustments include the appointment of Liu Miao as the head of strategic investment management and the focus of former Vice President Ma Jun on international business expansion [2]. Group 3: Strategic Implications - The incentive plan is seen as a critical institutional arrangement in the company's strategic transformation, aimed at providing talent support for its dual-driven strategy of consolidating its main business and expanding into emerging sectors [1][2]. - Industry insiders believe that by binding the interests of the core team with the company's medium- to long-term goals, Haimer Technology is positioned to enhance operational efficiency and accelerate its layout in emerging fields [3].

Group 1 - The core point of the article is that Koyuan Pharmaceutical (301281.SZ) has announced a draft for a restricted stock incentive plan for 2025, proposing to grant a total of 3 million restricted shares, which accounts for approximately 2.77% of the company's total share capital at the time of the announcement [1] - The plan includes an initial grant of 2.4 million restricted shares, with an additional 600,000 shares reserved [1] - The grant price for the restricted shares is set at 14.71 yuan per share [1] Group 2 - The effective period of the incentive plan will last from the date of the first grant of restricted shares until all granted shares are vested or become invalid, with a maximum duration of 48 months [1]

Core Viewpoint - Hekang New Energy (300048.SZ) announced a restricted stock incentive plan for 2025, aiming to enhance employee motivation and align interests with shareholders [1] Group 1 - The incentive plan proposes to grant a total of 29.73 million restricted shares, which represents 2.63% of the company's total share capital of 1,128.297357 billion shares as of the announcement date [1] - A total of 129 individuals will be the initial recipients of the restricted shares under this plan [1] - The grant price for the initially awarded restricted shares is set at 5.27 yuan per share, with the reserved portion of restricted shares having the same grant price [1]

Core Viewpoint - Haimer Technology (300084.SZ) has announced a draft for its 2025 restricted stock incentive plan, proposing to grant a total of 41.065 million shares, which accounts for 8.05% of the company's total share capital at the time of the announcement [1] Group 1 - The total number of restricted shares to be granted under the incentive plan is capped at 41.065 million shares [1] - The grant price for the restricted shares is set at 4.82 yuan per share [1] - The validity period of the incentive plan lasts from the completion of the registration of the granted restricted shares until the shares are fully released from restrictions or repurchased, with a maximum duration of 48 months [1]

Core Viewpoint - ST Lianchuang (300343.SZ) has announced a draft for its 2025 restricted stock incentive plan, proposing to grant a total of 11.1049 million restricted shares, which accounts for approximately 1.04% of the company's total share capital at the time of the announcement [1] Summary by Categories Incentive Plan Details - The incentive plan involves a one-time grant of restricted shares with no reserved rights [1] - The grant price is set at 3.50 yuan per share [1] - The effective period of the incentive plan lasts from the date of grant until the restricted shares are fully vested or become invalid, with a maximum duration of 36 months [1]

Core Viewpoint - ST Lianchuang (300343.SZ) has announced a draft for a restricted stock incentive plan for 2025, aiming to grant a total of 11.1049 million shares, which represents approximately 1.04% of the company's total share capital at the time of the announcement [1] Summary by Categories Incentive Plan Details - The incentive plan involves a one-time grant of restricted stock with no reserved rights [1] - The grant price is set at 3.50 yuan per share [1] - The effective period of the incentive plan lasts from the date of grant until the restricted stock is fully vested or becomes invalid, with a maximum duration of 36 months [1]

Core Viewpoint - Yachuang Electronics (301099.SZ) has announced a draft for its 2025 restricted stock incentive plan, aiming to enhance employee motivation and retention through stock ownership [1] Group 1: Incentive Plan Details - The number of restricted stocks to be granted under the incentive plan is 5.8 million shares, which represents 3.95% of the company's total share capital at the time of the announcement [1] - The grant price for the restricted stocks is set at 22.13 yuan per share [1] - The effective period of the incentive plan will last from the date of stock grant until all granted stocks are vested or become invalid, with a maximum duration of 36 months [1]

Group 1 - The core point of the article is that Yachuang Electronics (301099.SZ) has announced a draft for a restricted stock incentive plan for 2025, proposing to grant 5.8 million shares, which represents 3.95% of the company's total share capital at the time of the announcement [1] - The grant price for the restricted shares is set at 22.13 yuan per share [1] - The validity period of the incentive plan will last from the date of grant until the restricted shares are fully vested or become invalid, with a maximum duration of 36 months [1]

Core Viewpoint - XuanTai Pharmaceutical (688247.SH) announced a restricted stock incentive plan for 2025, aiming to grant up to 6.23 million shares, representing approximately 1.37% of the company's total share capital at the time of the announcement [1] Summary by Categories Incentive Plan Details - The plan proposes an initial grant of up to 4.99 million shares, accounting for about 80.06% of the total grant and approximately 1.10% of the company's total share capital [1] - A reserve of 1.24 million shares is included, which represents 19.94% of the total grant and about 0.27% of the company's total share capital [1] Stock Ownership Limits - As of the announcement date, the total number of shares involved in all effective stock incentive plans does not exceed 10.00% of the company's total share capital [1] - No individual incentive recipient can receive more than 1.00% of the company's total share capital through the stock incentive plan during its effective period [1]

Group 1 - The core point of the article is that Kexin Innovation Source (300731.SZ) has disclosed a draft for its 2025 restricted stock incentive plan, proposing to grant a total of 1.26 million shares, which accounts for approximately 0.997% of the company's total share capital at the time of the announcement [1] - The plan includes an initial grant of 1.01 million restricted stocks, divided into two categories: 252,000 shares of the first category and 1,008,000 shares of the second category [1] - The initial grant will be awarded to no more than 19 individuals, with a grant price (including reserved portion) set at 29.47 yuan per share [1]